Amir Nashat, Director at FATE THERAPEUTICS INC (FATE), sold 33,474 shares at $12.25 ($410K) on 2018-12-20, disclosed to the SEC on 2018-12-26.
Open-market sale of $410k FATE by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $12.25 | 221 | $3K | 0.7% |
| 2 | $12.25 | 323 | $4K | 1.0% |
| 3 | $12.25 | 630 | $8K | 1.9% |
| 4 | $12.25 | 32,300 | $396K | 96.5% |
| Total | $12.25 avg | 33,474 | $410K | 100% |
| Filing → |
| SRRK | BUY | 2022-06-24 | $6.2M | — | Filing → |
| MORF | SELL | 2021-05-25 | $20.4M | — | Filing → |
| MTCR | BUY | 2020-09-22 | $3.0M | — | Filing → |